CD8A and COVID-19: Compared to patients developing mild symptoms, CD4+ and CD8+ T cell populations from COVID-19 patients admitted to intensive care units (ICU) show reduced production of IL-2, a cytokine with major functions in enhancing T and B cell proliferation (11, 12).